Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bombardier

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Current Opinion in Rheumatology|May 6, 1998
A review of cost-effectiveness analyses in rheumatology and related disciplinesA Maetzel, M B Ferraz, C Bombardier
Spine|April 15, 1997
The Cochrane Collaboration Back Review Group for spinal disordersC Bombardier, R Esmail, A L Nachemson
Annals of Internal Medicine|November 15, 1991
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysisS E Gabriel, L Jaakkimainen, C Bombardier
The Journal of Rheumatology|March 15, 2001
Minimal clinically important difference. Low back pain: outcome measuresC Bombardier, J Hayden, D E Beaton
Arthritis and Rheumatism|April 1, 1990
Measurement of functional status, quality of life, and utility in rheumatoid arthritisM J Bell, C Bombardier, P Tugwell
Annals of the Rheumatic Diseases|December 5, 2008
Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysisW Katchamart, J Trudeau, V Phumethum, et al.
Spine|March 10, 2001
Surfing for back pain patients: the nature and quality of back pain information on the InternetL Li, E Irvin, J Guzmán, et al.
The New England Journal of Medicine|July 21, 1983
The effectiveness of a regulatory strategy in containing hospital costs. The Ontario experience, 1967-1981A S Detsky, S R Stacey, C Bombardier
American Journal of Industrial Medicine|June 1, 1996
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG)P L Hudak, P C Amadio, C Bombardier
The Journal of Rheumatology|April 1, 1995
Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study GroupC Bombardier, P M Peloso, C H Goldsmith
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Current Opinion in Rheumatology|May 6, 1998
A review of cost-effectiveness analyses in rheumatology and related disciplinesA Maetzel, M B Ferraz, C Bombardier
Spine|April 15, 1997
The Cochrane Collaboration Back Review Group for spinal disordersC Bombardier, R Esmail, A L Nachemson
Annals of Internal Medicine|November 15, 1991
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysisS E Gabriel, L Jaakkimainen, C Bombardier
The Journal of Rheumatology|March 15, 2001
Minimal clinically important difference. Low back pain: outcome measuresC Bombardier, J Hayden, D E Beaton
Arthritis and Rheumatism|April 1, 1990
Measurement of functional status, quality of life, and utility in rheumatoid arthritisM J Bell, C Bombardier, P Tugwell
Annals of the Rheumatic Diseases|December 5, 2008
Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysisW Katchamart, J Trudeau, V Phumethum, et al.
Spine|March 10, 2001
Surfing for back pain patients: the nature and quality of back pain information on the InternetL Li, E Irvin, J Guzmán, et al.
The New England Journal of Medicine|July 21, 1983
The effectiveness of a regulatory strategy in containing hospital costs. The Ontario experience, 1967-1981A S Detsky, S R Stacey, C Bombardier
American Journal of Industrial Medicine|June 1, 1996
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG)P L Hudak, P C Amadio, C Bombardier
The Journal of Rheumatology|April 1, 1995
Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study GroupC Bombardier, P M Peloso, C H Goldsmith
Pageof 18